After decay, Iodine-125 brachytherapy seeds lose their radioactivity and become stable. They no longer emit radiation and pose a reduced risk to surrounding tissues. The decay products may still remain in the body but at very low levels that are generally not harmful.
Iodine-131 decays through beta decay by emitting a beta particle and a gamma ray. This process transforms a neutron in the iodine-131 nucleus into a proton, resulting in the formation of xenon-131.
No, iodine-127 is not radioactive. It is a stable isotope of iodine, which means it does not undergo radioactive decay and does not emit harmful radiation.
The daughter product for the beta decay of iodine-136 is xenon-136. In beta decay, a neutron in the nucleus is converted into a proton, resulting in the emission of an electron (beta particle) and an antineutrino. This process transforms iodine-136 into xenon-136.
8.02 days
Here is the equation for the beta minus decay of iodine-131: 53131I => 54131Xe + e- + ve The iodine-131 undergoes a transformation when a down quark within a neutron in its nucleus changes into an up quark. This change is mediated by the weak interaction, or weak force. The neutron then becomes a proton, and an electron is created and ejected from the nucleus along with an antineutrino. To learn more, use the link below to the related question, "What is beta decay?"
Iodine-125 has 53 electrons. The number of electrons in an element is equal to its atomic number. Since iodine has an atomic number of 53, it has 53 electrons.
Iodine-131 is a radioactive isotope of iodine with 53 protons and 78 neutrons in its nucleus. It decays by beta decay, emitting beta particles and transforming into xenon-131.
Iodine-131 is a decaying radioisotope that produces xenon-131 through beta decay. During beta decay, a neutron is transformed into a proton within the nucleus, and a beta particle (an electron) is emitted, resulting in the production of xenon-131.
Assuming that "half" refers to "half-life", 360/60 = 6 so fraction left = 1/26 = 1/64
Iodine-125 is commonly used in medicine for brachytherapy, a form of radiotherapy in which radioactive sources are placed in close proximity to the target tissue to deliver localized radiation treatment, often for prostate cancer, brain tumors, and eye conditions like ocular melanoma.
The time required is 24.06 days. The half life of iodine 131 is 8.02 days.